Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
UK biotechs struggling to access finance as scale-up concerns grow
The UK Government has prioritised life science sector growth, but industry members have called for more funding.
Read Full Article
PharmaShots
Redefining Asthma Care: Caterina Brindicci and James Teague on Breztri Aerosphere’s US Approval and the Future of Triple Therapy Â
Shots Saurabh: The recent approval of Breztri Aerosphere in the US marks a pivotal moment in asthma care. From your perspective, what makes this milestone particularly significant for patients and the broader respiratory landscape? James: Breztri is now the first and only fixed‑dose triple‑combination therapy approved in the US as a maintenance treatment for patients 12 years of age and… The post Redefining Asthma Care: Caterina Brindicci and James Teague on Breztri Aerosphere’s US Approval and the Future of Triple Therapy  appeared first on PharmaShots.
Read Full Article
Pharma Tech
Novartis to acquire Myricx Bio in up to $1.5bn deal
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
Read Full Article
Pharma Tech
Roche pens $490m Astex breast cancer license deal
Roche’s breast cancer agreement with Astex is one of several oncology deals the Swiss pharma giant has inked in recent years.
Read Full Article
Pharma Tech
Besins Healthcare boosts drug delivery portfolio with UniD deal
Besins Healthcare has expanded its pharmaceutical operations with the acquisition of UniD Manufacturing, which specialises in long-acting drug delivery technologies.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Jul 6, 2026, 4:24 PM
UK biotechs struggling to access finance as scale-up concerns grow
The UK Government has prioritised life science sector growth, but industry members have called for more funding.
PharmaShots
Jul 6, 2026, 1:30 PM
Redefining Asthma Care: Caterina Brindicci and James Teague on Breztri Aerosphere’s US Approval and the Future of Triple Therapy Â
Shots Saurabh: The recent approval of Breztri Aerosphere in the US marks a pivotal moment in asthma care. From your perspective, what makes this milestone particularly significant for patients and the broader respiratory landscape? James: Breztri is now the first and only fixed‑dose triple‑combination therapy approved in the US as a maintenance treatment for patients 12 years of age and… The post Redefining Asthma Care: Caterina Brindicci and James Teague on Breztri Aerosphere’s US Approval and the Future of Triple Therapy  appeared first on PharmaShots.
PharmaShots
Jul 6, 2026, 12:29 PM
Pharvaris Reports the US FDA’s NDA Acceptance of Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
Shots: Ref: Globenewswire  |  Image: Pharvaris  | Press Release Related News: Ascletis Reports the US FDA’s IND Submission for ASC36 and ASC36_35 FDC to Treat Obesity PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Pharvaris Reports the US FDA’s NDA Acceptance of Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks appeared first on PharmaShots.
PharmaShots
Jul 6, 2026, 11:30 AM
Natera Reports Publication of Signatera MRD Test Results for Resected Metastatic Colorectal Cancer in JAMA Oncology
Shots: Ref: Businesswire  |  Image: Natera  | Press Release Related News: Natera Launches Zenith Genomics in the US to Diagnose Rare Diseases PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Natera Reports Publication of Signatera MRD Test Results for Resected Metastatic Colorectal Cancer in JAMA Oncology appeared first on PharmaShots.
PharmaShots
Jul 6, 2026, 10:30 AM
Astex Pharmaceuticals Partners with Genentech for Breast Cancer Therapy Program in a Deal Worth Over $515M
Shots: Ref: Globenewswire  |  Image: Genentech & Astex  | Press Release Related News: Genentech Reports the US FDA’s sBLA Acceptance of Lunsumio VELO + Polivy for R/R Large B-Cell Lymphoma PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Astex Pharmaceuticals Partners with Genentech for Breast Cancer Therapy Program in a Deal Worth Over $515M appeared first on PharmaShots.
Pharma Tech
Jul 6, 2026, 10:08 AM
Novartis to acquire Myricx Bio in up to $1.5bn deal
Novartis has signed an agreement to purchase Myricx Bio, a UK-based biotechnology company, in a transaction valued at up to $1.5bn.
News
Latest industry coverage
Google News
Jul 6, 2026, 6:52 PM
Novartis to Acquire Myricx Bio for $1.1 Billion - Pharmaceutical Executive
Novartis to Acquire Myricx Bio for $1.1 Billion  Pharmaceutical Executive
Google News
Jul 6, 2026, 6:44 PM
Katalyze AI Raises $10.5M Led by Bonfire Ventures Deploy Agentic Operating System for Pharma - The AI Journal
Katalyze AI Raises $10.5M Led by Bonfire Ventures Deploy Agentic Operating System for Pharma  The AI Journal
Google News
Jul 6, 2026, 6:40 PM
FDA to fast-track Regeneron drug facility in Saratoga County - Times Union
FDA to fast-track Regeneron drug facility in Saratoga County  Times Union
Google News
Jul 6, 2026, 6:18 PM
Katalyze AI thinks the future of pharma operations is teams of AI agents - BetaKit
Katalyze AI thinks the future of pharma operations is teams of AI agents  BetaKit
Google News
Jul 6, 2026, 5:23 PM
Roche pens $490m Astex breast cancer license deal - Pharmaceutical Technology
Roche pens $490m Astex breast cancer license deal  Pharmaceutical Technology
Google News
Jul 6, 2026, 5:23 PM
The New Rules of Biotech Now Available in Hardcover and Audiobook - NewMediaWire
The New Rules of Biotech Now Available in Hardcover and Audiobook  NewMediaWire
Google News
Jul 6, 2026, 5:13 PM
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? - The Motley Fool
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?  The Motley Fool
Google News
Jul 6, 2026, 5:09 PM
How Real-Time DTP Data Are Rewriting Pharma's Commercial Playbook - Pharmaceutical Commerce
How Real-Time DTP Data Are Rewriting Pharma's Commercial Playbook  Pharmaceutical Commerce
Google News
Jul 6, 2026, 4:50 PM
This ETF Is Up Nearly 17% in a Month and Doesn’t Own a Single Share of Nvidia - 24/7 Wall St.
This ETF Is Up Nearly 17% in a Month and Doesn’t Own a Single Share of Nvidia  24/7 Wall St.
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer